Search - tctmd.com

Displaying 81 - 100 of 323

Sort: Relevancy | Date

News Conference News EuroPCR 2022

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

Michael O'Riordan

May 20, 2022

News Conference News STS 2022

Modified Surgical MV Repair Stands Up to Replacement

Michael O'Riordan

February 03, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Conference News PCR London Valves 2021

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

Shelley Wood

November 26, 2021

Presentation TCT 2021

New Insights From COAPT

Presenter: Gregg Stone

November 05, 2021

Presentation TCT 2021

Changes in Left Ventricular Global Longitudinal Strain in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Stephan Milhorini Pio

November 04, 2021

Presentation TCT 2021

Temporary Implantation of the CroiValve DUO Coaptation Valve in Patients with Massive and Torrential Tricuspid Regurgitation

Presenter: Stephen O'Connor

November 04, 2021

News Daily News

Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR

Yael L. Maxwell

November 03, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2021

Shelley Wood

October 01, 2021

News Conference News ESC 2021

New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT

Shelley Wood

August 28, 2021

News Daily News

Endpoint Reporting in Medical Journals Needs to Be Revamped: Review

Michael O'Riordan

August 17, 2021

News Conference News TVT 2021

Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’

Todd Neale

July 27, 2021

Presentation TVT 2021

Improved Leaflet Coaptation by Chordal Grasping: The Mistral Repair System (Mitralix)

Presenter: Haim Danenberg

July 22, 2021

News Conference News TVT 2021

Timing of Mitral Surgery After Failed TEER Influences Outcomes

Todd Neale

July 21, 2021

Presentation TVT 2021

TMVR Patient Eligibility and Clinical Trial Considerations in the Post-COAPT Era (MVARC II)

Presenter: Gregg Stone

July 21, 2021

Presentation TVT 2021

Should Patient Selection for TEER in FMR Be Limited to the COAPT Criteria?

Presenter: Sean Pinney

July 20, 2021

Presentation TVT 2021

Rehospitalization and Mortality in Patients With Heart Failure and Secondary Severe Mitral Regurgitation: The COAPT Trial

Presenter: Gennaro Giustino

July 20, 2021

Presentation TVT 2021

Predictors of Reduction in Mitral Regurgitation by the MitraClip - Durable, Transient, or Failures in the COAPT Trial

Presenter: Scott Lim

July 20, 2021

News Daily News

Complete Revascularization Best for Most ACS Patients With MVD

Michael O'Riordan

June 25, 2021

News Conference News EuroPCR 2021

Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances

Caitlin E. Cox

May 21, 2021

Advertisement

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

Modified Surgical MV Repair Stands Up to Replacement

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

New Insights From COAPT

Changes in Left Ventricular Global Longitudinal Strain in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Temporary Implantation of the CroiValve DUO Coaptation Valve in Patients with Massive and Torrential Tricuspid Regurgitation

Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR

TCTMD’s Top 10 Most Popular Stories for September 2021

New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT

Endpoint Reporting in Medical Journals Needs to Be Revamped: Review

Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’

Improved Leaflet Coaptation by Chordal Grasping: The Mistral Repair System (Mitralix)

Timing of Mitral Surgery After Failed TEER Influences Outcomes

TMVR Patient Eligibility and Clinical Trial Considerations in the Post-COAPT Era (MVARC II)

Should Patient Selection for TEER in FMR Be Limited to the COAPT Criteria?

Rehospitalization and Mortality in Patients With Heart Failure and Secondary Severe Mitral Regurgitation: The COAPT Trial

Predictors of Reduction in Mitral Regurgitation by the MitraClip - Durable, Transient, or Failures in the COAPT Trial

Complete Revascularization Best for Most ACS Patients With MVD

Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content